Neuralgic amyotrophy

G6_NEURAMYO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G54.5
  • Hospital discharge: ICD-9 3535
  • Cause of death: ICD-10 G54.5
  • Cause of death: ICD-9 3535

2 out of 7 registries used, show all original rules.

65

4. Check minimum number of events

None

65

5. Include endpoints

None

65

6. Filter based on genotype QC (FinnGen only)

65

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G54
Name in latin
Amyotrophia neuralgica

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 398 163 231
Only index persons 371 152 219
Unadjusted period prevalence (%)
Whole population 0.01 0.00 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 52.03 50.89 52.84
Only index persons 51.07 50.12 51.73

-FinnGen-

Key figures

All Female Male
Number of individuals 65 25 40
Unadjusted period prevalence (%) 0.01 0.01 0.02
Median age at first event (years) 60.58 58.50 61.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
60
Matched controls
599
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G54.5
ICD-10 Finland
Neuralgic amyotrophy
+∞
83.3
59
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
16.1
8.9
14
11
TAB00
NOMESCO Finland
Lumbar puncture
18.0
8.7
13
9
R4120
NOMESCO Finland
Occupational therapy
12.4
7.5
13
13
N03AX16
ATC
pregabalin; oral
5.0
6.8
24
70
G56.0
ICD-10 Finland
Carpal tunnel syndrome
30.2
6.4
8
*
G54.9
ICD-10 Finland
Nerve root and plexus disorder, unspecified
+∞
6.4
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
7
12.79
4.93
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
10
8.93
4.19
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
11
8.10
3.99
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
13
6.84
3.62
1.3
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
32
175
2.63
3.56
4.8
5.9
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
18
5.62
3.51
1.3
1.2
e6/l
343.4
198.6
—
9
13
(3006315) Basophils [#/volume] in Blood
42
265
2.65
3.45
6.2
5.9
e9/l
0.0
0.0
0.74
37
230
(3016018) Differential panel - Cerebral spinal fluid
6
7
9.28
3.33
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
7
9.28
3.33
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
7
9.28
3.33
1.3
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
42
270
2.57
3.24
6.4
5.9
e9/l
2.7
2.0
0.39
37
241
(3001604) Monocytes [#/volume] in Blood
41
263
2.51
3.15
6.4
5.8
e9/l
0.6
0.6
0.24
36
229
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
33
198
2.35
2.86
1.8
2.0
pmol/l
96.8
88.0
0.41
19
105
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
15
5.09
2.67
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
91
2.54
2.66
1.3
1.3
iu/ml
22.8
24.0
—
6
29
(3023368) Bacteria identified in Blood by Culture
26
146
2.30
2.57
5.7
4.8
—
—
—
0
0
(4027681)
5
8
6.65
2.41
1.2
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
36
238
2.15
2.34
3.1
4.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
13
4.96
2.33
1.5
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
49
377
2.22
2.02
3.9
4.0
mm/h
12.9
11.6
0.18
49
345
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
11
4.82
1.98
1.2
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
11
4.82
1.98
1.2
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
12
4.41
1.86
1.4
1.2
g/l
0.2
0.3
—
5
12
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
13
4.07
1.75
1.4
1.2
g/l
1.1
1.3
—
5
13
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
71
2.24
1.69
1.1
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
26
172
1.85
1.53
3.0
2.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
19
113
1.96
1.53
3.4
2.5
e6/l
3.4
3.3
0.03
19
104
(3032080) INR in Blood by Coagulation assay
31
220
1.78
1.44
5.2
8.9
inr
1.2
1.3
—
10
58
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
61
2.19
1.44
1.8
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
32
231
1.76
1.39
9.8
9.4
e9/l
0.0
0.0
0.62
27
188
(3005719) IgG [Mass/volume] in Serum or Plasma
9
44
2.21
1.33
5.3
2.9
g/l
8.1
10.1
—
9
39
(40758558) Short blood count panel - Blood
22
146
1.77
1.25
9.9
6.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
19
2.76
1.24
1.4
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
19
2.76
1.24
1.2
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
19
2.76
1.24
1.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
65
2.04
1.23
1.9
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
39
2.20
1.20
1.7
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
47
388
1.76
1.20
4.0
3.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
13
206
0.54
1.15
2.1
2.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
67
1.97
1.14
1.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
41
2.08
1.13
2.3
16.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
32
2.33
1.12
3.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
22
2.37
1.05
7.0
3.0
g/l
2.9
3.9
—
5
16
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
22
2.37
1.05
7.0
3.0
g/l
7.0
7.4
—
5
17
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
22
2.37
1.05
7.0
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
50
1.93
1.02
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
70
1.88
1.01
1.3
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
23
164
1.62
0.99
4.9
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
59
539
2.02
0.94
23.1
14.8
mg/l
25.9
23.9
0.14
47
423
(3012516) Albumin [Mass/volume] in Urine
20
141
1.60
0.89
1.9
3.2
mg/l
142.2
60.5
0.29
13
97
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
19
133
1.61
0.86
2.4
2.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
27
207
1.52
0.83
4.1
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
56
509
1.72
0.82
20.9
13.5
ml/min/173m2
84.4
81.1
0.55
50
415
(3001019) Free T4 and TSH panel - Serum or Plasma
0
24
0.00
0.81
0.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
0
25
0.00
0.81
0.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
13
84
1.68
0.79
2.5
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
15
101
1.63
0.79
4.3
2.1
e6/l
2.2
0.9
—
9
52
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
110
1.60
0.78
1.8
2.0
mg/l
0.6
1.1
1.00
11
92
(3004588) Protein electrophoresis panel - Serum or Plasma
7
39
1.89
0.75
8.7
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
27
211
1.48
0.75
3.8
3.8
ng/l
18.3
43.0
0.96
18
150
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
94
1.62
0.74
2.1
2.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
25
2.08
0.74
4.2
4.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
95
1.60
0.71
4.1
2.4
e6/l
1.6
1.6
—
8
46
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
131
1.52
0.69
2.8
3.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
21
159
1.47
0.67
2.2
3.8
mg/mmol
19.7
7.1
0.32
13
106
(3022621) pH of Urine by Test strip
5
29
1.78
0.65
1.4
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.61
0.0
2.8
—
—
—
0
0
(3009343) pH of Capillary blood
6
36
1.73
0.58
4.0
3.9
—
7.4
—
0
6
(3009542) Hematocrit [Volume Fraction] of Blood
54
495
1.54
0.57
23.6
16.1
%
40.5
40.7
0.09
38
379
(3007853) Bacteria identified in Skin by Aerobe culture
9
64
1.47
0.54
3.1
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
38
331
1.36
0.52
2.7
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
15
112
1.44
0.50
3.1
5.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
7
47
1.55
0.49
2.9
4.0
e9/l
68.4
75.9
—
7
41
(3020630) Protein [Mass/volume] in Serum or Plasma
7
47
1.55
0.49
8.9
3.0
g/l
65.7
66.5
—
7
42
(3037467) Urinalysis macro (dipstick) panel - Urine
41
364
1.34
0.48
3.5
4.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
27
227
1.32
0.45
1.8
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
31
266
1.32
0.45
3.2
4.5
estimate
0.0
0.0
—
6
52
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
32
1.61
0.43
5.8
27.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
8
59
1.41
0.43
3.0
3.9
%
1.8
2.0
—
8
52
(40768793) Breast Pathology biopsy report
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
17
0.00
0.41
0.0
4.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
35
1.46
0.40
1.2
1.2
—
—
—
0
0
(3013512) EKG study
20
164
1.32
0.39
3.9
4.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
41
1.51
0.37
1.3
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
42
1.47
0.37
2.0
4.0
—
—
—
0
0
(4010399)
6
43
1.43
0.36
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
31
272
1.27
0.36
2.5
3.5
estimate
0.0
0.0
—
6
48
(3022948) Iron [Moles/volume] in Serum or Plasma
6
86
0.67
0.36
2.2
2.2
umol/l
10.7
14.3
—
6
79
(3000991) Gas panel - Venous blood
6
46
1.33
0.34
5.8
9.5
—
—
—
0
0
(3019225) pH of Specimen
6
46
1.33
0.34
4.0
4.4
—
—
—
0
0
(3000492) Spirometry study
7
51
1.42
0.33
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
149
1.29
0.32
3.5
2.8
ug/l
0.5
0.7
0.80
13
104
(3041096) Erythrocytes [Presence] in Urine by Automated
11
140
0.74
0.32
2.0
3.1
—
—
—
0
0
(3015736) pH of Urine
23
197
1.26
0.32
2.6
3.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
71
0.68
0.28
11.4
8.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
17
144
1.24
0.25
4.2
2.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
39
1.31
0.23
1.2
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
5
41
1.24
0.22
2.4
2.8
kpa
3.8
4.7
—
5
41
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.6
—
5.7
—
0
5
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
12
0.00
0.21
0.0
3.6
—
17.2
—
0
6
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
48
1.27
0.21
4.5
3.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
6
50
1.22
0.20
3.0
3.9
kpa
5.9
5.7
—
6
50
(3008037) Lactate [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
3.1
—
1.5
—
0
14
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.9
—
66.0
—
0
14
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
3.1
—
7.0
—
0
14
(3002256) Pathology report gross observation
7
57
1.26
0.19
1.3
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
8
68
1.20
0.17
2.0
1.9
%
1.8
1.6
—
8
60
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
6
75
0.78
0.16
2.0
2.3
%
21.8
23.7
—
6
67
(3003694) ABO and Rh group [Type] in Blood
15
131
1.19
0.16
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
22
201
1.14
0.14
4.0
4.3
%
24.3
20.6
—
9
101
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
43
1.18
0.10
1.0
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
13
144
0.88
0.09
3.5
4.0
estimate
0.0
0.0
—
6
49
(3012544) pH of Venous blood
6
54
1.12
0.09
3.0
4.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
10
113
0.86
0.09
4.2
4.0
—
1.0
—
0
13
(3002385) Erythrocyte distribution width [Ratio]
47
456
1.11
0.08
27.9
17.9
%
13.6
14.1
1.53
47
448
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
19
204
0.90
0.08
3.1
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
8
76
1.06
0.08
1.1
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
4.8
—
24.8
—
0
6
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
268.5
—
0
6
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
56
0.88
0.00
1.2
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.4
—
106.9
—
0
9
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
24.5
—
0
5
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
6
65
0.92
0.00
6.5
1.7
ug/g
174.2
151.2
—
6
54
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.4
—
3.9
—
0
9
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
55
0.90
0.00
1.4
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
80
1.00
0.00
1.3
1.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.5
—
0
5
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
3.9
—
48.8
—
0
7
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
3.0
—
1.5
—
0
9
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
59
1.02
0.00
1.2
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
8
0.00
0.00
0.0
1.1
—
17.3
—
0
8
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.7
—
35.1
—
0
7
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
12.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_NEURAMYO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_NEURAMYO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: G6_NEURAMYO – Neuralgic amyotrophy

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data